Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Nina Shah

Proteasome Inhibitor-Induced Modulation Reveals the Spliceosome as a Specific Therapeutic Vulnerability in Multiple Myeloma

Nature Communications

English

A Randomized Phase 2 Trial of a Preparative Regimen of Bortezomib, High-Dose Melphalan, Arsenic Trioxide, and Ascorbic Acid

English

Durable Remission With Salvage Second Autotransplants in Patients With Multiple Myeloma

English

Long-Term Follow-Up of Patients Receiving Allogeneic Stem Cell Transplant for Chronic Lymphocytic Leukaemia: Mixed T-Cell Chimerism Is Associated With High Relapse Risk and Inferior Survival

British Journal of Haematology

Hematology

2017

English

Revised-International Staging System (R-Iss) Is Predictive and Prognostic for Early Relapse (<24 Months) After Autologous Transplantation for Newly Diagnosed Multiple Myeloma (MM)

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2019

English

Immunoregulatory B Cells Are Enriched Within Transitional and IgM Memory B Cell Subsets in Healthy Donors but Are Reduced and Functionally Impaired in Patients With Chronic Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2014

English

Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2017

English

Myeloablative Timed Sequential Busulfan Is Safe in Patients With Relapsed or High-Risk Multiple Myeloma

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2016

English

Dual Donor T-Cell Chimerism Does Not Predict Poor Prognosis After Double Cord Blood Allogeneic Transplantation

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2015

English

Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2013

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Nina Shah

Proteasome Inhibitor-Induced Modulation Reveals the Spliceosome as a Specific Therapeutic Vulnerability in Multiple Myeloma

A Randomized Phase 2 Trial of a Preparative Regimen of Bortezomib, High-Dose Melphalan, Arsenic Trioxide, and Ascorbic Acid

Durable Remission With Salvage Second Autotransplants in Patients With Multiple Myeloma

Long-Term Follow-Up of Patients Receiving Allogeneic Stem Cell Transplant for Chronic Lymphocytic Leukaemia: Mixed T-Cell Chimerism Is Associated With High Relapse Risk and Inferior Survival

Revised-International Staging System (R-Iss) Is Predictive and Prognostic for Early Relapse (<24 Months) After Autologous Transplantation for Newly Diagnosed Multiple Myeloma (MM)

Immunoregulatory B Cells Are Enriched Within Transitional and IgM Memory B Cell Subsets in Healthy Donors but Are Reduced and Functionally Impaired in Patients With Chronic Graft-Versus-Host Disease

Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Myeloablative Timed Sequential Busulfan Is Safe in Patients With Relapsed or High-Risk Multiple Myeloma

Dual Donor T-Cell Chimerism Does Not Predict Poor Prognosis After Double Cord Blood Allogeneic Transplantation

Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome